NERV Minerva Neurosciences, Inc PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Minerva Neurosciences (NERV) Stock: Buy, Sell, or Hold?

$2.38
-0.18 (-7.03%) â–ŧ
5d: +3.48% 30d: +1.28% 90d: -48.03%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (56%)
Quality Score
40/100
Position
FAIR
30-Day Fair Range
$2.19 – $2.92
Position: FAIR
Forward P/E & Valuation
-5.7x
Next 12M consensus est.
Wall Street Target
$10.33
+334.2% upside
Options IV & Volume
25th pct IV
HIGH volume confirmation
Support / Resistance
$1.96 / $2.76
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: NERV is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.

Get Alerted When NERV Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: NERV is currently trading at $2.38, which is considered fair relative to its 30-day fair value range of $2.19 to $2.92.

Technical Outlook: Technically, NERV is in a strong downtrend. Immediate support is located at $1.96, while resistance sits at $2.76. Short-term momentum is weak, with the stock down 7.0% recently.

Market Sentiment: NERV scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (25th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $10.33 (+334.2%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $2.19 - $2.92
Company Quality Score 40/100 (HOLD)
Options IV Signal 25th percentile (LOW)
Volume Confirmation HIGH
Confidence Score 56.2%

Trading Range & Key Levels

30-Day Trading Range $2.19 - $2.92
Current vs Trading Range FAIR
Expected Move (7 Days) Âą$0.54 (22.8%)
Support Level $1.96
Resistance Level $2.76
Current Trend Strong Downtrend
Technical data as of Nov 12, 2026

Quantitative Signal Breakdown

  • NEUTRAL: Price in fair range
  • BULLISH: Options cheap (IV 25th percentile)
  • BEARISH: Weak technical setup (20/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-7.0%)
  • BULLISH: Trading 334.2% below Wall St target ($10.33)
  • WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -5.67
Wall Street Target $10.33 (+334.2%)
Share NERV Analysis

Share this live NERV analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (NERV)

Bearish 2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 14, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits shows 100.0% bullish sentiment towards $NERV with no recent news articles available.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:34 PM ET
Data refreshes hourly during market hours. Next update: 8:34 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for NERV.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALNY
Alnylam Pharmaceuticals â€Ļ
STRONG BUY
30 analysts
$302 51 HOLD
VRTX
Vertex Pharmaceuticals Iâ€Ļ
STRONG BUY
32 analysts
$592 39 SELL
ONC
BeOne Medicines AG
STRONG BUY
27 analysts
$438 30 SELL
ASND
Ascendis Pharma AS
STRONG BUY
21 analysts
$304 36 SELL
ORIC
Oric Pharmaceuticals Inc
STRONG BUY
15 analysts
$22 67 BUY

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive NERV Research Pages
NERV Technical Chart NERV Price Prediction NERV Intrinsic Value DCF NERV Earnings Date NERV Investment Advisor NERV Fair Price Analyzer NERV Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals